Durham, NC, United States of America

Deanna Trojan Garrison


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2005

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Celebrating the Innovations of Deanna Trojan Garrison

Introduction

Deanna Trojan Garrison is a prominent inventor located in Durham, North Carolina. With a focus on innovative pharmaceutical compounds, Deanna has made significant contributions to the medical field. Her work primarily targets the treatment of Alpha-1A mediated diseases or conditions, demonstrating her commitment to advancing healthcare solutions.

Latest Patents

Deanna holds a patent for her groundbreaking invention titled "Imidazoline derivatives as alpha-1A adrenoceptor ligands." This patent involves a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof. Such compounds hold great potential in treating urinary incontinence, highlighting her invention's medical relevance and applicability.

Career Highlights

Deanna's career has been marked by her role at SmithKline Beecham Corporation, where she has leveraged her expertise to develop innovative pharmaceutical solutions. Her dedication and ingenuity have positioned her as a key player within her organization.

Collaborations

Throughout her career, Deanna has collaborated with esteemed colleagues, including Eric Cleveland Bigham and Michael Joseph Bishop. These partnerships reflect her ability to work effectively within a team, driving forward innovative solutions in her field.

Conclusion

Deanna Trojan Garrison's contributions as an inventor underscore the importance of innovation in the medical industry. With a patent focused on addressing critical health conditions, her work exemplifies the impact that dedicated inventors can have on society. As she continues her journey at SmithKline Beecham Corporation, the future undoubtedly holds more remarkable innovations from her.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…